arrow_back Civic Audit
Share share

Boosting US Drug Production: New Center for Biomanufacturing Excellence.

This law authorizes $120 million to establish a National Biopharmaceutical Center of Excellence aimed at accelerating the domestic production of advanced medicines. The goal is to secure the supply chain for critical drugs, reduce reliance on foreign manufacturers, and ensure faster access to innovative treatments for citizens. This initiative is expected to enhance health security and create specialized jobs.
Key points
Establishes a National Center of Excellence to research and scale up the manufacturing of biopharmaceuticals within the United States.
Strengthens domestic supply chains for critical medicines, reducing the risk of shortages and dependency on foreign sources.
Funds workforce training programs to develop skilled labor for the high-tech biotechnology and pharmaceutical sectors.
article Official text account_balance Process page notifications_active Track this Bill
Status: Introduced
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_HR_6089
Sponsor: Rep. Houlahan, Chrissy [D-PA-6]
Process start date: 2025-11-18